PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY TYPE • Market segmentation by type • Comparison by type • Medications - Market size and forecast 2018-2023 • Procedures - Market size and forecast 2018-2023 • Market opportunity by type PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 10: MARKET TRENDS PART 11: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 12: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • ALLERGAN • Bayer AG • Lumenis • Merck & Co., Inc. • Pfizer Inc. PART 13: APPENDIX • Research methodology • List of abbreviations PART 14: EXPLORE TECHNAVIO   Exhibit 01: Global pharmaceuticals market Exhibit 02: Segments of global pharmaceuticals market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: Type - Market share 2018-2023 (%) Exhibit 18: Comparison by type Exhibit 19: Medications - Market size and forecast 2018-2023 ($ millions) Exhibit 20: Medications - Year-over-year growth 2019-2023 (%) Exhibit 21: Procedures - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Procedures - Year-over-year growth 2019-2023 (%) Exhibit 23: Market opportunity by type Exhibit 24: Customer landscape Exhibit 25: Market share by geography 2018-2023 (%) Exhibit 26: Geographic comparison Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 28: North America - Year-over-year growth 2019-2023 (%) Exhibit 29: Top 3 countries in North America Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Europe - Year-over-year growth 2019-2023 (%) Exhibit 33: Top 3 countries in Europe Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 35: Asia - Year-over-year growth 2019-2023 (%) Exhibit 36: Top 3 countries in Asia Exhibit 37: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 38: ROW - Year-over-year growth 2019-2023 (%) Exhibit 39: Top 3 countries in ROW Exhibit 40: Key leading countries Exhibit 41: Market opportunity Exhibit 42: Trending advanced hair removal devices Exhibit 43: Comparison between standard therapies and substitute therapies Exhibit 44: Impact of drivers and challenges Exhibit 45: Vendor landscape Exhibit 46: Landscape disruption Exhibit 47: Vendors covered Exhibit 48: Vendor classification Exhibit 49: Market positioning of vendors Exhibit 50: ALLERGAN - Vendor overview Exhibit 51: ALLERGAN - Product segments Exhibit 52: ALLERGAN - Organizational developments Exhibit 53: ALLERGAN - Geographic focus Exhibit 54: ALLERGAN - Segment focus Exhibit 55: ALLERGAN - Key offerings Exhibit 56: ALLERGAN - Key customers Exhibit 57: Bayer AG - Vendor overview Exhibit 58: Bayer AG - Business segments Exhibit 59: Bayer AG - Organizational developments Exhibit 60: Bayer AG - Geographic focus Exhibit 61: Bayer AG - Segment focus Exhibit 62: Bayer AG - Key offerings Exhibit 63: Bayer AG - Key customers Exhibit 64: Lumenis - Vendor overview Exhibit 65: Lumenis - Business segments Exhibit 66: Lumenis - Organizational developments Exhibit 67: Lumenis - Key offerings Exhibit 68: Lumenis - Key customers Exhibit 69: Merck & Co., Inc. - Vendor overview Exhibit 70: Merck & Co., Inc. - Business segments Exhibit 71: Merck & Co., Inc. - Organizational developments Exhibit 72: Merck & Co., Inc. - Geographic focus Exhibit 73: Merck & Co., Inc. - Segment focus Exhibit 74: Merck & Co., Inc. - Key offerings Exhibit 75: Merck & Co., Inc. - Key customers Exhibit 76: Pfizer Inc. - Vendor overview Exhibit 77: Pfizer Inc. - Business segments Exhibit 78: Pfizer Inc. - Organizational developments Exhibit 79: Pfizer Inc. - Geographic focus Exhibit 80: Pfizer Inc. - Segment focus Exhibit 81: Pfizer Inc. - Key offerings Exhibit 82: Pfizer Inc. - Key customers Exhibit 83: Validation techniques employed for market sizing

ALLERGAN Bayer AG Lumenis Merck & Co., Inc. Pfizer Inc.